健康【2021 ASH】亞盛醫藥抗耐藥白血病新藥奧雷巴替尼臨床進展第四次...2022-09-22CML受試者奧雷巴HQP1351TKI產品摘要編號形式奧雷巴替尼(HQP1351)Updated Safety and Efficacy Results of Phase 1 Study of Olverembatinib (HQP1351), a Novel Third-Ge...